Cellebrite CEO Ramji Shiven Receives RSU Award

What Happened

• Ramji Shiven, CEO of Cellebrite DI Ltd. (CLBT), received an award of 38,505 restricted share units (RSUs) on September 24, 2026. The grant price is $0.00 (an award), so no cash was paid. Each RSU represents a contingent right to receive one ordinary share of the company upon settlement.

Key Details

• Transaction date: 2026-09-24; Form filed: 2026-09-25 (timely).
• Transaction type/code: A — Grant/Award.
• Shares/units granted: 38,505 RSUs; price per unit: $0.00; total cash value at grant: $0.
• Vesting schedule (per footnote): 9,633 RSUs vest on May 4, 2027, then 2,406 RSUs vest every three months thereafter through May 4, 2030.
• Each RSU converts to one ordinary share upon settlement (subject to vesting and any plan terms).
• Post-transaction beneficial ownership: not specified in this Form 4.
• No 10b5-1 plan, tax-withholding sale, or late filing indicated in the filing.

Context

• RSU grants are a common form of executive compensation and vest over time, aligning executives with shareholder value but not representing an immediate purchase or sale. Because these are time-vesting awards, they do not indicate an immediate market transaction or direct insider buying/selling motivation.